Neuromodulators are the key ingredient allowing motor networks the flexibility to produce multiple patterns of output. When one considers a task such as stepping, a number of patterns need to be produced to run, walk, hop, go up and down inclines and walk in a circular pattern. While we focus on stepping in this review, neuromodulators contribute to the rhythmic operation of most, if not all, biological networks. A complete understanding of the role of neuromodulators in motor control must take into account the combinatorial effects of the complement of transmitters released both synaptically and extrasynaptically. This is an immense challenge for the field of motor control, especially when small invertebrate motor circuits are compared directly with their larger, less accessible and more complex mammalian cousins. However, in the last decade new genetic tools have become available that allow spinal circuits that compose a motor network to be identified (Goulding, [@B144]). In addition, the birth of optogenetics and pharmacogenetics has provided advanced tools for activating and inactivating neuromodulatory systems (Shapiro et al., [@B163]; Aston-Jones and Deisseroth, [@B3]). Even with these new tools it will still be a challenge to examine and comprehend the combinatorial role of multiple neurotransmitters, but the task is more tractable than it has been historically.

Although many neuropeptides, hormones or monoamines can modulate motor circuits, our review will focus on the role of dopamine. Dopamine plays an important role in the activation and modulation of the motor system across a wide range of invertebrate and vertebrate species (Harris-Warrick et al., [@B147]; Svensson et al., [@B126]; Puhl and Mesce, [@B105]; Miles and Sillar, [@B159]; Clemens et al., [@B29]; Lambert et al., [@B74]). In humans, movement disorders such as Parkinson's disease and Restless Leg Syndrome provide prime examples of what can happen and how debilitating it can be for the individual when the dopaminergic system is compromised. Because of this, a large degree of effort has been focused on understanding the contribution and mechanisms of supraspinal dopamine to motor control. Considerably less attention has been paid towards the descending dopaminergic projections to motor networks in the spinal cord compared to the descending serotonergic and noradrenergic systems. We will discuss and contrast current knowledge of the descending dopaminergic system with the descending serotonergic and noradrenergic system in the control of locomotion in a variety of species, with particular focus on work conducted in the rodent.

Dopamine's role in locomotion {#s1}
=============================

Across invertebrate and vertebrate species, dopamine has profound and diverse effects on rhythmically active motor networks. These actions are a result of a complex modulation of intrinsic cellular properties and synaptic connectivity (for review see Harris-Warrick et al., [@B147]). Remarkably, in some species dopamine demonstrates the ability to reconfigure circuits or networks to generate completely different motor behaviors (Puhl and Mesce, [@B105]; Crisp et al., [@B143]; Puhl et al., [@B162]). More recent studies have highlighted the ability of dopamine to shape a motor network during development, producing a change in motor behaviors from immature to more mature adult-like behaviors (Lambert et al., [@B74]). Furthermore, dopamine also possesses the capacity to promote developmental and adult motor neurogenesis (Reimer et al., [@B110]).

Early exploration of the role of catecholamines in locomotor behaviors in the 1960's determined that L-DOPA could modulate reflex circuits and promote locomotor activity, although at the time it was thought to be of noradrenergic origin (Jankowska et al., [@B63],[@B64]; Grillner and Zangger, [@B48]). For many years, L-DOPA was used to evoke locomotor activity in spinalized cats. It was later demonstrated that L-DOPA could promote air stepping in the neonatal rodent (Sickles et al., [@B120]; McCrea et al., [@B89]; McEwen et al., [@B158]), an effect that is blocked by both noradrenergic (Taylor et al., [@B164]) and dopaminergic antagonists (Sickles et al., [@B120]). This work established that catecholamines act on networks that generate locomotion. This work was unclear on the individual effects of dopamine, or the products of dopamine synthesis (noradrenaline) on locomotion and whether they were acting within the spinal cord. Additional studies now suggest that noradrenaline and dopamine both contribute to the control of locomotion in a different way than the predominant spinal serotonergic system that contributes to both evoking and modulating locomotor behavior (Forssberg and Grillner, [@B41]; Kiehn et al., [@B72]; Whelan et al., [@B134]; Jordan et al., [@B151]; Humphreys and Whelan, [@B61]).

Dopamine's role in rhythmicity: invertebrates {#s2}
=============================================

Work from invertebrate species has largely influenced the way that we view modulation of motor systems. For example, the stomatogastric nervous system is a well-defined series of interconnected ganglia that controls the rhythmic filtering and chewing motor patterns of the crab and lobster foregut. The effector ganglion, specifically known as the stomatogastric ganglion (STG), consists of 26--30 neurons that generate a pacemaker-driven higher frequency pyloric rhythm and a conditionally active and lower frequency gastric mill rhythm. Neuromodulation profoundly reconfigures this small circuit, biasing individual neurons to participate in the different motor behaviors. Within even the simplest of nervous systems rhythmic behaviors are not hard-wired, and neuromodulation imbues networks with the flexibility to generate multiple patterns of motor output (Marder, [@B86]; Gutierrez et al., [@B51]). Dopamine modulates every aspect of the pyloric circuit including intrinsic membrane properties such as I~A~(Harris-Warrick et al., [@B145]; Kloppenburg et al., [@B155]), I~h~ (Peck et al., [@B160]), I~CAN~ (Kadiri et al., [@B152]), I~K(V)~ (Gruhn et al., [@B49]), the strength and dynamics of graded and spike-dependent synaptic transmission (Johnson and Harris-Warrick, [@B148]; Johnson et al., [@B150], [@B149]; Kvarta et al., [@B156]) and even properties of the axon spike initiation zone itself (Bucher et al., [@B141]). It is pertinent to acknowledge that dopamine produces concentration dependent rhythms in both vertebrates and invertebrates (Clemens et al., [@B29]) and therefore the state of the network can be affected by neuromodulatory tone. Harris-Warrick and Johnson ([@B146]) have reviewed data demonstrating that dopamine can produce opposing effects on multiple conductances in individual neurons of the circuit. This complex modulation depends on the cell type, but the central idea is that dopamine prevents (at least in the STG) runaway modulation of the circuits. Less is known about the role dopamine plays in the gastric mill rhythm. We still do not fully understand the role of dopamine within this circuit; a sobering realization considering the complexity of spinal cord CPG circuits. What we can learn from work on invertebrates is that a neuromodulator can have a strong influence on individual cells, and even differential effects on individual cells in a circuit. However, if we are to understand the overall modulation of motor behavior we need to consider the combinatorial actions of many neuromodulators on network function and not simply one in isolation. There is another factor at play, namely that network output often remain remarkably robust despite neuromodulatory inputs. Furthermore, a change in network output pattern can be elicited in multiple ways through degenerate mechanisms (Gutierrez et al., [@B51]). This work is an important extension of previous findings showing that a large number of solutions exist even within a simple circuit for the production of a single behavior (Prinz et al., [@B161]).

Work from the laboratory of Karen Mesce in the medicinal leech (*Hirudo Medicinalis*) illustrates that dopamine has a profound effect on locomotor behaviors, highlighting its ability to bias the network toward a particular motor output or reinforce an ongoing behavior. Specifically, dopamine acts as a command signal to elicit crawling along with suppression of swimming (Puhl and Mesce, [@B105]; Crisp et al., [@B143]; Puhl et al., [@B162]), and is an excellent example of the ability of dopamine to bias locomotor behavior (Crisp and Mesce, [@B34]). Dopamine has a similar effect in nematodes (e.g., *Caenorhabditis elegans)* where it also acts to bias locomotor activity to a crawl pattern of activity over swimming (Vidal-Gadea et al., [@B165]). Similar to neuromodulation of the STG, dopamine could be acting on overlapping populations of neurons that are involved in two separate behaviors (Briggman et al., [@B140]), biasing circuit configuration output toward one output over the other.

Dopamine's role in locomotion: aquatic and amphibious species {#s3}
=============================================================

In the lamprey, dopamine elicits a complex modulatory effect on swimming behavior similar in some respects to rhythmically active motor behaviors of invertebrates. Spinal dopamine is released from a number of sources including small cells located around the central canal that send projections into the CSF of the central canal (Ochi et al., [@B99]; McPherson and Kemnitz, [@B93]; Pierre et al., [@B104]), and also in a more ventrally-located plexus of cells that co-release serotonin and interact with the complex dendritic process of motor neurons (Schotland et al., [@B118]). There are also descending dopaminergic projections from the hypothalamus that may play a role in modulating spinal networks, but their role with respect to locomotion is not well understood (Barreiro-Iglesias et al., [@B9]). Therefore, the lamprey exhibits both intrinsic and extrinsic dopaminergic neuromodulation of spinal circuits. Because of the co-release of locally-produced spinal dopamine and serotonin, their effect will be discussed in parallel. When bath applied to the spinal cord *in vitro*, serotonin reduces the frequency and increases the amplitude of locomotor bursting activity in a dose dependant manner (Harris-Warrick and Cohen, [@B54]), an effect that is mediated by 5-HT~1A~ receptors and is readily reproduced in the freely swimming animal (Kemnitz et al., [@B70]). These effects are elicited by presynaptic inhibition of descending Muller cells which would result in reduced descending excitation of locomotor circuits (Buchanan and Grillner, [@B21]; Shupliakov et al., [@B119]). In addition, serotonin also directly reduces the late afterhyperpolarization (AHP) in motor neurons, lateral interneurons (van Dongen et al., [@B131]), crossed caudal commissural interneurons and giant interneurons (Wallén et al., [@B132]). Dopamine appears to have more complex effects, whereby low concentrations (0.1--10 µM) result in an increase in locomotor frequency, higher concentrations (10--100 µM) slow the rhythm, and concentrations as high as 100 µM--1 mM can suppress the rhythm (Harris-Warrick and Cohen, [@B54]; McPherson and Kemnitz, [@B93]; Schotland et al., [@B118]; Svensson et al., [@B126]). The increase in locomotor frequency can be reproduced in freely swimming animals (Kemnitz et al., [@B70]) and is believed to be mediated by selective D~2~ receptor mechanisms (McPherson and Kemnitz, [@B93]). It was initially proposed that this effect was exerted by decreasing the calcium-dependant potassium channel (SK~Ca~) and reducing the late component of the AHP in neurons such as edge cells, dorsal cells and giant interneurons, although these cells are not strong contributors to rhythmogenesis. It is more likely that the influence on rhythm frequency is due to a reduction in inhibitory drive from inhibitory commissural interneurons (Kemnitz, [@B154]). Concentration dependent dopamine effects are also observed in tadpoles, where effects on mainly D~2~ receptors were observed at low concentrations with D~1~ effects emerging when concentrations of dopamine were increased (Clemens et al., [@B29]).

The slowing effect of dopamine on locomotor activity at higher concentrations was unclear until recently, but is now believed that it may be acting on convergent mechanisms with that of 5-HT. Both 5-HT~1A~ and D~2~ receptors appear to reduce post-inhibitory rebound (PIR) on inhibitory commissural interneurons that generate left-right alternation of swimming by reducing the calcium conductance through the CaV~1.3~ channel (Hill et al., [@B57]; Wang et al., [@B133]). Assuming the organization of a classical half center, the authors suggested that the reduction in PIR would decrease the efficiency of the transition from inhibition to excitation, thus reducing the overall frequency of the alternating pattern.

In contrast to the lamprey, spinal dopamine appears to have a transient effect on swimming in the larval zebra fish with depressive effects at 3 days post fertilization (dpf) becoming less potent by 5 dpf (Thirumalai and Cline, [@B129]). Further work demonstrates that dopamine contributes to the development and maturation of locomotor networks in the spinal cord (Lambert et al., [@B74]). The sole source of spinal dopamine in the zebrafish is the Orthopedia (transcription factor, *otp*) neurons of the midbrain forming the dopaminergic diencephalospinal tract (DDT) that send descending projections to the spinal cord (McLean and Sillar, [@B91],[@B92]). *Otp* transcription factors are conserved in mammalian species and are expressed in the A11 dopaminergic neurons of the mouse, and analogous areas of the zebrafish, which project to the spinal cord (Ryu et al., [@B116]). In the zebrafish, it appears that these neurons develop around 3 dpf and act on the D~4~ receptor to reconfigure the locomotor network to generate a more mature form of locomotor behavior; by 4 dpf the actions have switched, from spontaneous swim episodes consisting of infrequent, long duration bursts to frequent and short duration bursting episodes of swimming (Lambert et al., [@B74]). Such a modification in locomotor behavior is presumably critical for survival, as it would allow the animal to engage in more active locomotor behaviors associated with foraging whereas the immature form is more directed toward the escape from larger predatory fish. More recent investigation of the spinal dopaminergic system in the zebrafish has demonstrated that the D~4a~ receptor also acts on neural progenitor cells via sonic hedgehog signaling to promote motor neuron generation over V2 interneurons during the first 24--48 h post fertilization; an effect that can be recapitulated to promote neuronal regeneration following spinal cord injury (SCI; Reimer et al., [@B110]). Dopamine does not work alone in shaping the motor network during development. There is evidence that the descending serotonergic system also plays an important role in the development of a mature swimming pattern after the switch occurs at 4 dpf (Brustein et al., [@B20]). This points to the possibility that dopamine may play a role in promoting the network shift and serotonin may play more of a role in the modulation of a more mature network in the zebrafish. This is consistent with the idea proposed from work in the STG whereby different monoamines likely act simultaneously and rarely on their own.

More is known with respect to the monoaminergic modulation of locomotor networks by serotonin in the *Xenopus* tadpole. In the larval *Xenopus*, the modulatory role of serotonin on fictive swimming activity is to increase burst duration and intensity with no effect on cycle period, thus promoting a stronger swimming pattern (Sillar et al., [@B121]). This is in contrast to the noradrenergic system which acts to bias the motor output toward a lower frequency and weaker bursting pattern of activity (Sillar et al., [@B121]). Similar to the lamprey (Wang et al., [@B133]), both serotonin and noradrenaline modulate locomotor activity through converging mechanisms. However, in the X*enopus* they influence the strength of inhibitory post synaptic potentials evoked by glycinergic commissural interneurons projecting to motor neurons via modulation of presynaptic release of glycine from commissural terminals (McDearmid et al., [@B90]). More specifically, serotonin reduces release of glycine whereas noradrenaline increases glycine release from these terminals onto motor neurons (McDearmid et al., [@B90]). In the larval X*enopus* locomotor network, dopamine reduces locomotor activity via D~2~-like mechanisms at low concentrations (1--5 µM) and promotes locomotor activity at higher concentrations (10--50 µM) via D~1~-like mechanisms (Clemens et al., [@B29]). The precise neuronal populations being acted on are unknown. The development of limbed locomotion in the frog from swimming in the tadpole affords a unique opportunity to study the developmental and potentially evolutionary reconfiguration of the neuronal networks mediating the two different, yet similar, forms of locomotion. In the metamorphosing froglet, with both immature limbs and a tail for swimming still intact, both noradrenaline and serotonin bias locomotor network output controlling either the tail or the developing legs. Specifically, serotonin acts to slow rhythmic tail-associated swimming activity and speeds up the limb-associated activity, whereas noradrenaline will speed up tail-associated swimming activity and slow down limb-associated activity. This provides yet another example of opposing aminergic modulation of distinct spinal locomotor circuits and their functional coupling during amphibian metamorphosis (Rauscent et al., [@B109]). These are similar to modulatory interactions influencing the pyloric and gastric mill rhythms in the STG (Gutierrez et al., [@B51]) and expression of swimming and crawling behaviors in the medicinal leech (Crisp and Mesce, [@B34]; Puhl and Mesce, [@B105]).

Biochemical and neuroanatomical aspects of descending dopaminergic systems in mammals {#s4}
=====================================================================================

Walking behavior in terrestrial legged mammals recruits up to 80 individual muscles. While the activity of all of them has not been measured during walking, all indications are that each muscle generates a uniquely patterned burst. This adds another layer of complexity to aquatic based species by adding on components of the network that produce not only left-right alternation but also coordination of flexor and extensor muscles within limbs. In mammalian systems, the role of dopamine in rhythmic motor behaviors is less well understood. That said, data collected thus far suggest a modulatory role qualitatively similar to that observed in the lamprey.

Catecholamine-containing cells {#s5}
==============================

Around the same time that the robust influence of monoamines on long-latency flexor reflex afferents and their relationship to half-center function was being discovered in mammalian motor systems in the early 1960's (Jankowska et al., [@B63],[@B64]; Grillner and Zangger, [@B48]; Baker et al., [@B4]), nuclei of serotonin and catecholamine-containing cells were described in the mammalian midbrain and hindbrain. These findings were largely based on approaches that utilized histochemical staining against dopamine and noradrenaline (Carlsson et al., [@B22]; Dahlström and Fuxe, [@B36]), later using more modern immunohistochemical approaches to detect the presence of the enzyme tyrosine-hydroxylase (TH; Hökfelt et al., [@B60]). Based on such criteria, these cells were coined aminergic cells, or A-cells, and permitted discrete nuclei to be identified and named A1--A17 (Carlsson et al., [@B22]; Dahlström and Fuxe, [@B35]; Hökfelt et al., [@B59]). Advances in immunohistochemical methods were later used to identify cells that express other enzymes involved in the synthesis of catecholamines such as aromatic amino acid decarboxylase (AADC), dopamine-β-hydroxylase (D*β*H) and phenylethanolamine-N-methyl-transferase (PNMT; Figure [1](#F1){ref-type="fig"}). These developments allowed for further characterization between the types of catecholamine-producing cells. The original view that catecholamine-producing cell types consist of dopaminergic, noradrenergic, and adrenergic classes has been expanded and there is evidence of enzymatic diversity within each class. For example, some TH positive cells lack any enzymes for conversion to traditional catecholamine neurons. Others have a portion, but not all, of the enzymatic machinery. A prime example of these cells are the D-cells which contain AADC but lack TH and are situated around the central canal of the spinal cord (Jaeger et al., [@B62]). They are similar in location and structure to the dopamine-producing LC cells in the lamprey spinal cord (Ochi et al., [@B99]; McPherson and Kemnitz, [@B93]; Pierre et al., [@B104]) and the AADC^+^/TH^−^ D cells of the zebrafish spinal cord (Chatelin et al., [@B24]). While the function of these cells is not clear, the bottom line is that catecholaminergic phenotypes are more complex than originally thought. Nevertheless, cells that express TH, AADC and are DβH negative can still provide a good indication that the cells may be dopaminergic whereas the DβH positive cells could be either noradrenergic or adrenergic. Such criteria permitted for the identification of nine major dopaminergic nuclei in the brain (Björklund and Dunnett, [@B13]). The canonical dopaminergic cell would also express machinery for dopamine release such as a vesicular monoaminergic transporter (VMAT2) to pump dopamine into vesicles, a reuptake transporter like the dopamine transporter (DAT) and a means of regulating release of dopamine such as presynaptic D~2~ autoreceptors (Ugrumov, [@B130]). It is important to note however that some dopamine neurons differentially express D~2~ autoreceptors. The mechanisms of actions at the soma and terminals may also be different (G protein-coupled inwardly-rectifying potassium channel (GIRK) versus Kv1.2 respectively) and some TH^+^ neurons may not even express them at all (Pappas et al., [@B101]; Ford, [@B40]). Therefore, expression of D~2~ autoreceptors may not be a pre-requisite of a canonical dopamine cell, but may be a common feature. In fact, diversity appears the rule rather than the exception for catecholaminergic cell types (Ugrumov, [@B130]).

![**The canonical catecholaminergic neuron is one that generates dopamine, noradrenaline or adrenaline**. Catecholamines are synthesized from tyrosine through a series of biosynthetic steps progressing from tyrosine hydroxylase (TH) producing L-DOPA, aromatic amino acid decarboxylase (AADC) producing dopamine, dopamine-β-hydroxylase (DBH) producing noradrenaline and phenylethanolamine-N-methyl-transferase (PNMT) producing adrenaline. These neurons also express the vesicular monoaminergic transporter (VMAT2) to pump catecholamines into synaptic vesicles. A canonical dopaminergic neuron will also express dopamine reuptake transporters (DAT) and inhibitory D~2~ autoreceptors to regulate presynaptic release of dopamine. Post synaptic targets of dopamine include the excitatory D~1~-like and inhibitory D~2~-like receptors that act through G-protein second messenger cascades, increasing and decreasing intracellular cAMP levels respectively.](fncir-08-00055-g0001){#F1}

Descending catecholaminergic projections {#s6}
========================================

The predominant sources of spinal dopamine and noradrenaline in mammals are the descending fibers projecting from the dopaminergic A10 and A11 nuclei of the posterior hypothalamus (Björklund and Skagerberg, [@B14]; Lindvall et al., [@B80]; Skagerberg and Lindvall, [@B122]; Qu et al., [@B106]; Pappas et al., [@B101]), the A13 of the dorsal hypothalamus (Blessing and Chalmers, [@B15]) and the pontine noradrenergic A5, A6 (locus coeruleus) and A7 nuclei (Fritschy and Grzanna, [@B42]; Clark and Proudfit, [@B28]; Bruinstroop et al., [@B19]). While these regions appear to be conserved in many mammalian species including primates and humans (Moore and Bloom, [@B96]; Barraud et al., [@B8]), we will focus on these regions with emphasis on rodent anatomy as they are best described in these species. The A11 is a small nucleus in the posterior hypothalamus consisting of approximately 150--300 neurons (Figure [2](#F2){ref-type="fig"}) and is the primary source of spinal dopamine in mammalian species. A11 neurons are thought to be L-DOPAergic based on the absence of AADC in non-human primates, although the evidence in rodents is mixed (Barraud et al., [@B8]). This suggests a possibility that L-DOPA release in the spinal cord of the non-human primate could be converted to dopamine by other cells using spinally located AADC such as that present in the D cells near the central canal (Jaeger et al., [@B62]). It appears that dopaminergic neurons in the A11 go against what a canonical dopaminergic neuron would look like, since A11 neurons lack the reuptake transporter DAT (Lorang et al., [@B82]; Ciliax et al., [@B27]) as well as D~2~ auto-receptors (Pappas et al., [@B101]). The lack of D~2~ autoreceptors would presumably increase release probability for dopamine as well as TH enzyme activity (Kehr et al., [@B69]; Wolf and Roth, [@B136]; Benoit-Marand et al., [@B12]; Ford, [@B40]). One possibility is that the A11 phenotype serves as a compensatory adaptation given their few numbers in order to prolong the release, and increase synthesis, of dopamine to their targets in the ventral horn.

![**Descending dopaminergic fibres within the spinal cord originate in the A11.** **(A)** Dopamine acts on all five dopamine receptors that are distributed non-uniformly through the dorsal and ventral horns of the spinal cord (Adapted with permission from Zhu et al., [@B139]). Descending noradrenergic fibres originating in the A5, A6 and A7 nuclei of the pons innervate the spinal cord. Schematic adapted with permission from Björklund and Dunnett ([@B13]).](fncir-08-00055-g0002){#F2}

Although the A11 connectome is not well characterized, it has been shown that the A11 receives inputs from a number of regions including lateral septum, parabrachial nucleus, infralimbic cortex and the bed nucleus of the striata terminalis (Abrahamson and Moore, [@B1]; Qu et al., [@B106]). The A11 also receives inputs from the suprachiasmatic nuclei (SCN), suggesting that A11 neurons may be modulated in a circadian pattern (Zhao et al., [@B138]). There is evidence that this might be the case as the expression of the rate limiting enzyme TH is modulated in a circadian pattern, generating high levels of spinal dopamine during awake periods (Hammar et al., [@B30]). It has also been suggested that AADC is expressed in a circadian pattern, which may also describe the variable findings to date (Björklund and Dunnett, [@B13]; Barraud et al., [@B8]).

The best characterized of the A11 efferent projections are the descending axons that travel through the dorsal longitudinal fasciculus of Schutz, located in the periaqueductal gray, and descend unilaterally through the dorsolateral funiculus into the superficial dorsal horn. A small number of axons also descend in the regions around the central canal and into the ventral horn (Björklund and Skagerberg, [@B14]; Commissiong et al., [@B33]; Skagerberg and Lindvall, [@B122]), with higher densities in the lumbar region relative to the thoracic regions (Pappas et al., [@B101]). Several examples have been provided by Pappas et al. ([@B101], [@B102]), indicating sexual dimorphism of the descending A11 system whereby males have a greater number of dopaminergic neurons and a higher density of descending fibers with no apparent difference in dopamine metabolism (Pappas et al., [@B101], [@B102]). Overall, it has been suggested that this dimorphism, which is androgen-dependant (Pappas et al., [@B102]), may contribute to the higher female prevalence of restless leg syndrome, a motor disorder associated with impairments in the spinal dopaminergic system (Pappas et al., [@B101]). To better understand how the A11 exerts its influence on locomotor behavior, the connectivity of the A11 with other locomotor-related regions in the brain needs to be established. In addition to the spinal cord, A11 neurons project collaterals to the dorsal raphe nucleus and the prefrontal cortex (Peyron et al., [@B103]). It is possible that other targets are likely.

In parallel to A11 projections, noradrenergic fibers of the A5, A6 and A7 travel through the lateral and ventral funiculi and dorsal surface of the dorsal horn. A particularly high density of fibers from the A5 can be found in the lateral region, A6 in the dorsal and ventral regions and A7 mainly in the lateral region. Previously the termination sites of descending noradrenergic projections were controversial (Fritschy and Grzanna, [@B42]; Clark and Proudfit, [@B28]). More recent transgenic approaches have revealed that the A5 regions provides the densest innervation of the thoracic sympathetic preganglionic neurons, A6 densest in the dorsal horn at all levels of the spinal cord and the A7 densest in the ventral horn at all levels of the spinal cord (Bruinstroop et al., [@B19]). Such an organization would suggest that the A5 nucleus would exert more of an influence over autonomic functions, A6 over modulation of sensory input and A7 to motor function. Interestingly, in regards to dopamine innervation of the spinal cord, there is also a clear autonomic innervation of the intermediolateral nucleus of the spinal cord from the A11. Together with noradrenaline this suggests multiple effects of catecholamines on most inputs and outputs of the spinal cord.

Both descending dopaminergic and noradrenergic projections to the spinal cord share similarities in terms of fiber distribution and points of innervation within the gray matter of the spinal cord, but there are differences in terms of fiber density. Dopaminergic fibers appear to develop slower than noradrenergic fibers. Noradrenergic fiber density appears to peak at 14 days after birth with some pruning taking place up to early adulthood. On the other hand dopamine fiber development occurs slowly throughout development in the spinal cord, peaking at early adulthood (Commissiong, [@B31]). Generally speaking, the descending fibers heavily innervate the dorsal horns where catecholaminergic influence is exerted via diffuse paracrine release, whereas relatively less innervation of the ventral horn is reported, specifically in lamina IX where direct synaptic connections are made on medium to large dendrites with few axo-somatic synapses of motor neurons (Yoshida and Tanaka, [@B137]; Rajaofetra et al., [@B107]; Ridet et al., [@B112]). Much more is known about the nature of synaptic interaction of motor neurons by the descending noradrenergic and serotonergic fibers. Noradrenergic and serotonergic input to motor neuron pools have typically been described as diffuse (Heckman et al., [@B55]; Johnson and Heckman, [@B67]); however, recently the nature of synaptic targets was further described for noradrenergic and serotonergic neurons in cat splenius motor neurons (Montague et al., [@B95]) and appear to be concentrated on small diameter distal dendrites of motor neurons with few located on somal targets. This distribution implies compartmentalization of synaptic contacts, which has also been suggested as playing an important role in regulating the input-output properties of motor neurons (Montague et al., [@B95]).

Targets of spinal dopamine {#s7}
==========================

Dopamine receptors are G-protein coupled receptors and are divided into two subfamilies; the D~1~-like receptors (D~1~ and D~5~) and the D~2~-like receptors (D~2~, D~3~, and D~4~). Generally, activation of the D~1~-like receptor subfamily elicits excitatory effects through a stimulatory G-protein (G~sα~) interacting with adenyl cyclase, subsequently increasing intracellular cAMP levels. In contrast, activation of the D~2~- receptor subfamily hyperpolarizes the cell membrane through an inhibitory G-protein (G~iα~) to close calcium channels, open potassium channels and reduce intracellular cAMP levels (Missale et al., [@B94]). In the rodent, dopamine released from terminals in the lumbar spinal cord can act on all five dopamine receptors (D~1~--D~5~; Figure [2](#F2){ref-type="fig"}) which are non-uniformly distributed across the transverse lumbar spinal cord (Zhu et al., [@B139]). Similar to other monoamines, the distribution of receptors is species dependent (Barraud et al., [@B8]) and their density is likely also developmentally regulated as dopaminergic receptors are in other areas of the brain (Tarazi and Baldessarini, [@B128]). Little is known in respect of the rostrocaudal distribution but higher levels of dopamine are found in cervical, opposed to lumbar, segments of the spinal cord (Karoum et al., [@B153]). In the juvenile mouse, D~2~-like receptor subtypes are strongly expressed in lamina I-III of the dorsal horn with the predominant subtype being the D~3~ receptor (Levant and McCarson, [@B78]). This distribution has been suggested to mediate dopamine's anti-nociceptive effects. D~1~-like receptors are most strongly expressed in the ventral horn where the motor circuits reside with motor neurons in particular, expressing all five receptor types (Zhu et al., [@B139]). While *in situ* hybridization techniques have been able to describe the location in the spinal cord where dopamine receptors are expressed, what remains unknown is whether receptors are compartmentalized within different regions of the identified neurons such as is the case for noradrenergic and serotonergic receptors in cat motor neurons (Montague et al., [@B95]). These factors could contribute to complex modulation of motor neuron input-output properties and network-based effects reflected by dopamine's complex effects on locomotor activity. More recently, when the non-human primate spinal cord was examined for dopaminergic expression, a different distribution pattern from rodents was observed. Specifically, no evidence for D~1~ mRNA was observed anywhere in the spinal cord, although D~5~ mRNA was found in the dorsal horn. Overall there appears to be a dorsal horn emphasis for dopamine expression in non-human primates compared to rodents (Barraud et al., [@B8]).

Functional effects of spinal dopamine on locomotor networks {#s8}
===========================================================

Descending catecholamine release has been observed during locomotion (Gerin et al., [@B38]; Gerin and Privat, [@B45]) and both dopamine and noradrenaline are capable of promoting locomotion when exogenously introduced to the intact animal (Barbeau and Rossignol, [@B6], [@B7]; Rossignol et al., [@B113]). That said, a large amount of what we know about the influence of dopamine on the spinal locomotor networks has been derived from *in vitro* investigations of fictive locomotor activity of the neonatal rodent spinal cord studied in isolation (Whelan et al., [@B134]; Barrière et al., [@B11]; Gordon and Whelan, [@B46]; Humphreys and Whelan, [@B61]; Christie and Whelan, [@B142]). Unlike serotonin, which is a potent activator of the locomotor central pattern generator (CPG) network across a variety of mammalian species (Harris-Warrick and Cohen, [@B54]; Schmidt and Jordan, [@B117]; Madriaga et al., [@B83]; Liu and Jordan, [@B81]; Gabriel et al., [@B43]), dopamine alone can elicit fictive locomotor activity in the rat (Kiehn and Kjaerulff, [@B71]; Barrière et al., [@B11], but not in the mouse, although D~1~ agonists alone appear to be sufficient for locomotion (Sharples et al., [@B166]). Bath application of dopamine on its own is sufficient to evoke rhythmic motor activity. However, the low frequency rhythm does not resemble a functional locomotor pattern characterized by left-right and flexor-extensor alternation (Sqalli-Houssaini and Cazalets, [@B124]; Figure [3](#F3){ref-type="fig"}). The differential observations with respect to the ability of dopamine and D~1~ agonists to evoke locomotor activity are not yet clear. One possibility is that non-specific binding of dopamine to both D~1~-like and D~2~-like receptor subtypes may act to suppress the full expression of locomotor activity. Noradrenaline does not appear to be capable of eliciting stable locomotor activity in either the isolated rat or mouse spinal cord (Kiehn et al., [@B72]; Sqalli-Houssaini and Cazalets, [@B124]). The reasons for the differences between rat and mice in the case of dopamine are unknown but, in the cases where locomotor activity cannot be produced, these two catecholamines generally elicit robust modulatory effects on the lumbar networks (Kiehn et al., [@B72]; Sqalli-Houssaini and Cazalets, [@B124]; Gordon and Whelan, [@B46]; Humphreys and Whelan, [@B61]).

![**Dopaminergic modulation of spinal CPG activity**. **(A)** Schematic of an *in vitro* isolated neonatal mouse spinal cord showing ventral root neurograms from the left and right L2 segment. **(B)** Spontaneous activity **(Bi)** is converted to a rhythmic slow non-locomotor rhythmic pattern **(Bii)** following bath application of dopamine (DA). **(C and D)** When DA is bath-applied during ongoing locomotor activity elicited by 5-HT and NMA it stabilizes and reduces the frequency of the rhythm. The spectrogram **(D)** depicts a cross-wavelet analysis of a locomotor rhythm evoked by 5-HT and NMA (box 1) and effect of dopamine (DA) on the pre-existing rhythm (box 2 and 3). Rhythm frequency is displayed on the *y*-axis and rhythm power displayed as warm or cool colors with warmer colors representing higher power or more stable rhythm. Dopamine also increases burst amplitude **(Ei** and **Eii)**. **(Ei)** Graph displays an increase in burst amplitude over a 10 min period immediately following the addition of dopamine and **(Eii)** shows an average L2 neurogram burst from a representative experiment with bursts evoked by 5-HT and NMA (black) and following addition of dopamine (red) (Adapted from Humphreys and Whelan, [@B61]).](fncir-08-00055-g0003){#F3}

The behavior of the catecholamines on mammalian motor rhythms should not be surprising in the context of what has been described in the STG where, in all likelihood, neuromodulators influence rhythmic motor behaviors in parallel and rarely in isolation (Marder, [@B86]). This combinatorial neuromodulation is more evident when ongoing locomotor activity elicited by serotonin and NMA/NMDA is examined where both dopamine and noradrenaline reduce the frequency of the rhythm and increase burst amplitude, resulting in an overall more robust rhythm (Kiehn and Kjaerulff, [@B71]; Sqalli-Houssaini and Cazalets, [@B124]; Barrière et al., [@B11]; Gordon and Whelan, [@B46]; Humphreys and Whelan, [@B61]). In other words, these two catecholamines may be promoting ongoing locomotor activity and these qualities are often exploited by incorporating dopamine into the "locomotor cocktail" to elicit robust locomotor activity in investigations that deploy *in vitro* isolated spinal cord models (Whelan et al., [@B134]).

While neurochemical activation of neonatal locomotor circuits has provided a great amount of insight into the function of locomotor circuits, studies that use models that allow for activation of endogenous neuromodulators are few. In particular, the generation of new models is lacking that allow activation of *in vitro* circuits by direct stimulation of supraspinal nuclei. While these types of studies have been published for serotonin through stimulation of the parapyramidal region of the medulla (Liu and Jordan, [@B81]), comparable studies have not been performed for catecholamine systems. Furthermore, *in vivo* and developmental studies are required to establish whether dopamine release onto spinal circuits is *necessary* for locomotor activity. This is especially true in neonatal rodents where monoaminergic innervation takes place over 3 weeks following birth (Commissiong, [@B31]; Bregman, [@B18]; Rajaofetra et al., [@B108]).

The receptor mechanisms that mediate the network-based effects of dopamine on locomotor activity are not fully understood. It is likely that dopamine is acting to promote locomotor activity through excitatory influences of D~1~-like receptors in rodents, whereas the slowing effect on fictive locomotor frequency is through inhibitory D~2~-like receptor mechanisms. Indeed, there is consistent evidence across adult and neonatal preparations that the D~1~-like receptor subfamily promotes locomotor activity (Barrière et al., [@B11]; Lapointe and Guertin, [@B75]; Lapointe et al., [@B76]). In contrast, much less is known regarding the role of D~2~-like receptors in the control of locomotion (Barrière et al., [@B11]) despite their presence in the ventral horn (Zhu et al., [@B139]). Activation of the D~2~-like receptor subfamily suppresses recurrent excitatory feedback to the locomotor network, most likely via presynaptic mechanisms (Maitra et al., [@B84]; Humphreys and Whelan, [@B61]), but the functional role in the modulation of rhythmically active motor circuits in the mammalian spinal cord remains elusive. Further dissection of these receptor mechanisms requires examination of the dopaminergic influence of individual spinal reflex circuits and known components of the spinal locomotor network. Dopamine does elicit potent effects on spinal sensorimotor reflex circuits and has been an area of interest in the context of restless leg syndrome (Carp and Anderson, [@B23]; Jensen and Yaksh, [@B65]; Tamae et al., [@B127]; Barriere et al., [@B10]; Keeler et al., [@B68]). D~3~ receptor suppression of primary afferent input to the dorsal horn has been suggested to mediate dopaminergic suppression of the monosynaptic reflex (Hammar et al., [@B30]) and has been implicated with restless leg syndrome given that D~3~ receptor agonists exert potent therapeutic effects at alleviating motor hyperactivity (Manconi et al., [@B157]). D~2~-mediated inhibition of primary afferents and post synaptic neurons in the substantia gelatinosa (Tamae et al., [@B127]) have been suggested to be anti-nociceptive acting at the dorsal horn; an influence that would work in parallel to excitation of motor circuits to promote motor function. What is not well understood is how dopamine may modulate proprioceptive inputs to spinal cord locomotor circuits. In work by Jankowska on the cat, noradrenergic and serotonergic modulation is complex and consists of both excitatory and inhibitory components onto commissural interneurons (Hammar et al., [@B30]). Similar heterogeneity of dopamine actions is likely but remains underexplored. What is known is that L-DOPA, whether exerting its effect through dopaminergic or noradrenergic systems, modulates afferent reflex circuits by shutting down short latency reflexes and opening up long latency reflexes (Jankowska et al., [@B63],[@B64]). This classic work by Anders Lundberg and colleagues showed systemic injection of L-DOPA could reveal an interneuronal network that could result in flexor-extensor alternating movements when flexor and extensor afferents were stimulated simultaneously. This was taken as cellular evidence for Graham-Brown's half-center concept (Graham-Brown, [@B47]; Stuart and Hultborn, [@B125]).

Dopamine has also been shown to modulate synaptic connectivity and intrinsic properties of some known components of the locomotor network (Han et al., [@B52]; Han and Whelan, [@B53]). The ability of dopamine to promote ongoing locomotor activity may be due to combined effects exerted on motor neurons, premotor interneurons and Hb9-expressing interneurons that participate at all levels of the spinal locomotor network (Figure [4](#F4){ref-type="fig"}; Han et al., [@B52]; Han and Whelan, [@B53]). In the neonatal mouse, dopamine acts to depolarize motor neurons as well as premotor interneurons that project through the ventrolateral funiculus (Han et al., [@B52] Figure [4A](#F4){ref-type="fig"}). It appears that dopamine is a necessary component to evoke stable rhythmic bursting activity in classes of genetically identified spinal interneurons (Hb9 cells; Hinckley et al., [@B58]; Wilson et al., [@B135]) when introduced with 5-HT and NMDA but is not sufficient to do so on its own (Han et al., [@B52]); however, other studies suggest that NMDA alone is sufficient (Masino et al., [@B88]). Dopamine also increases the excitability of motor neurons by reducing the potassium currents I~A~ and SK~ca~, but the receptor mechanisms mediating this effect are not known (Figure [4](#F4){ref-type="fig"}; Han et al., [@B52]). In addition, dopamine increases synaptic AMPA currents onto motor neurons via D~1~-like receptor-PKA mechanisms and is analogous to findings in embryonic chick motor neurons mediated by increases in kainite-gated channels (Smith et al., [@B123]). Together, the combination of increased intrinsic excitability and excitatory synaptic input to motor neurons facilitate motor output; however, it remains unclear why dopamine alone might not be sufficient to evoke locomotor like activity. While these studies are instructive they have only begun to scratch the surface of the function of catecholamines *in vivo*.

![**Known effects of dopamine on cellular components of the locomotor network.** Ventral root neurograms from the L2, L5 and S1 segments and ventrolateral funiculus (VLF) of a spinal cord isolation preparation with fast synaptic transmission blocked (CNQX, AP5, PTX and Strychnine) indicates that dopamine increases the excitability of motor neurons projecting through ventral roots and interneurons projecting through the VLF (A) (Adapted from Han et al., [@B52]). Intracellular recordings from motor neurons show that dopamine increases motor neuron excitability indicated by an increase in the slope of the frequency-current relationship **(Bi** and **Bii)**. This effect is in part mediated by a reduction in I~A~ and SK~Ca~ conductances. Dopamine also increases AMPA conductances **(Ci** and **Cii)** via a D~1~-like receptor mechanisms (Adapted with permission from Han and Whelan, [@B53]). Dopamine reduces recurrent excitatory feedback to the locomotor CPG (Humphreys and Whelan, [@B61]) and Renshaw cells via D~2~-like receptor mechanisms (Maitra et al., [@B84]). A summary of all these effects are depicted in panel **(D)**.](fncir-08-00055-g0004){#F4}

Targeting monoaminergic systems post SCI to promote recovery {#s9}
============================================================

Motor impairment is particularly prominent following SCI when the influence from descending serotonergic, noradrenergic and dopaminergic inputs to the lumbar cord are lost or compromised. A number of approaches have been tested experimentally and clinically to promote recovery of motor function following injury and include promoting regeneration of damaged tracts (Hellal et al., [@B56]), reducing inflammation and subsequent secondary injury (Rowland et al., [@B115]; Kwon et al., [@B73]), and promoting plasticity within the spinal motor networks (Boulenguez and Vinay, [@B17]; Fong et al., [@B39]; Rossignol and Frigon, [@B114]). Because monoamines are potent activators of motor networks, they may serve as a suitable target for exciting and promoting recovery following an insult (Rémy-Néris et al., [@B111]).

Direct application of dopamine or noradrenaline is potentially a useful approach however both would need to be applied intrathecally to spinal segments. For these reasons either agonists or antagonists of catecholamine receptors that can cross the blood brain barrier have been investigated. In chronic spinalized cats, administration of an α~2~ agonist, clonidine, was able to elicit walking in acute spinal cats and promote recovery of function in chronic spinal animals (Forssberg and Grillner, [@B41]; Barbeau and Rossignol, [@B5]; Chau et al., [@B25]), but had the opposite effect in spinalized rats (Musienko et al., [@B98]). In spinalized mice, locomotor movements were elicited following administration of agonists affecting the D~1~ receptor system (Lapointe et al., [@B76]), and recent work demonstrates that administration of the D~2~ agonist quinpirole can stabilize gait and facilitate flexion. From these studies we can conclude that dopaminergic agonists potentiate stepping with D~1~ agonists in particular boosting extensor activity and weight-bearing support (Lapointe et al., [@B76]; Musienko et al., [@B98]). These data support findings of generalized excitation of motor neurons (Han et al., [@B52]; Han and Whelan, [@B53]), and stabilization of motor patterns with dopamine using *in vitro* mouse (Jiang et al., [@B66]; Whelan et al., [@B134]; Madriaga et al., [@B83]; Humphreys and Whelan, [@B61]) or rat (Barrière et al., [@B11]) preparations. Courtine and colleagues (Musienko et al., [@B98]) have recently shown that combinations of monoamines including agonists for 5-HT~1A~, 5-HT~2A~, D~1~ and antagonists for NA (α~2~) were particularly successful in producing locomotion that resembled normal stepping in spinalized rats, supported by data from *in vitro* preparations (Madriaga et al., [@B83]). A cautionary note is that tuning of these monoaminergic combinations will likely need to be performed before translation to humans in a non-human primate where the receptor expression resembles humans (Barraud et al., [@B8]). A final note on this topic is that there is evidence that monoamine receptors (5-HT~2C~) are constitutively expressed for months following a SCI in rodents and upregulation of these receptors may contribute to functional improvement in locomotion following injury (Murray et al., [@B97]). It is not known whether catecholaminergic receptors could contribute in a similar manner but dopamine D~5~ receptors do show high constitutive activity (Demchyshyn et al., [@B37]). D~5~ receptors are known to be constitutively active in the rat subthalamic nucleus after 6-OHDA treatment of the medial forebrain bundle. D~5~ receptors are expressed in the spinal cord and this remains a possibility for intervention (Chetrit et al., [@B26]). In this regard, an early report of increased dopamine receptor dependent adenyl cyclase following SCI may be relevant (Gentleman et al., [@B44]).

Another approach is using L-DOPA that is converted to dopamine and noradrenaline in catecholamine axon terminals and within D cells in the spinal cord. Even though descending catecholamine axons tend to degenerate following injury, D-cells may compensate by upregulating AADC (Jaeger et al., [@B62]; Li et al., [@B79]). In spinalized mice, administration of L-DOPA and buspirone (dopamine and 5-HT~1~ partial agonist) combined with apomorphine reliably elicited locomotor activity in mice with a complete spinal transection (Guertin et al., [@B50]). Work in decerebrate rats suggests that L-DOPA activation of locomotion is dopamine receptor dependent (Sickles et al., [@B120]; McCrea et al., [@B89]). In terms of translation, Maric et al. ([@B87]) showed that oral administration of L-DOPA did not produce any observable change in locomotor recovery following SCI. It is not clear why L-DOPA may have proven ineffective but it is likely that a combination of multiple catecholaminergic agonists will need to be developed for humans in combination with other therapies. In this regard, the use of embryonic cells from the dopaminergic ventral tegmental region may also be a useful strategy, similar to approaches that have used embryonic noradrenergic locus coeruleus (Commissiong, [@B32]) or serotonergic raphe cells implanted into the injury site (Majczyński et al., [@B85]; Boido et al., [@B16]).

It is useful to consider new genetic approaches that target monoaminergic sites. The field of optogenetics has developed methods to target classes of cells such that they can be excited or inhibited with light. This is accomplished by the insertion of light sensitive cation channels (e.g., Channelrhodopsin-2) for activation or proton pumps (e.g., archaerhodopsins) for silencing of neuronal activity that can be expressed based on cell-specific transcription factors or promoter regions (for review see: Aston-Jones and Deisseroth, [@B3]). The use of pharmacogenetics which make use of engineered receptors that respond to non-endogenous ligands could address difficulties of translation, as optogenetic approaches require light fibers to be implanted and would most likely need to cover multiple cord segments. In addition, these non-endogenous ligands can be introduced intravenously, intraperitoneally or orally (for review see: Lee et al., [@B77]). The most commonly utilized form of this technology are the designer receptors exclusively activated by designer drugs (DREADDS), which are modified metabotropic muscarinic receptors that respond to the non-endogenous ligand clozapine-N-oxide (CNO). Similar to optogenetic approaches, these receptors can be inserted into specific cell types under transcriptional control of cell-specific genes. Neuronal activity can be facilitated through insertion of the hm3 receptor form or silenced by insertion of the hm4 receptor form (Shapiro et al., [@B163]) by administration of CNO. This approach is considerably simpler than optogenetics, since hardware need not be installed and the CNO can be administered systemically. Following administration of the CNO, effects can be observed within tens of minutes and can last for hours. The next day the CNO will be metabolized and one can then repeat the experimental protocol. Using this approach one can target supraspinal nuclei containing monoaminergic cells in patients with incomplete SCI or direct activation of spinal circuits (Figure [5](#F5){ref-type="fig"}). This approach has promise since it allows for the remote activation of targets by administering artificial ligands that bind selectively to the artificial receptors targeted to the monoaminergic nucleus of interest. Other approaches to consider are the use of OptoXRs which activate similar cAMP processes as native α~2~ receptors (Airan et al., [@B2]). The OptoXR approach is light activated at the moment, but offers the opportunity to selectively upregulate α~2~ receptors in motor neurons for example. This technique would directly target second messenger pathways in targeted cells. In all likelihood, a combination of supraspinal plus spinal activation and inactivation strategies will need to be deployed to achieve optimal results. In most cases mentioned the tools used combine Cre-driver mice lines coupled with floxxed viral vectors. However, if translation is a consideration then it should be noted that delivery of DREADDs, opsins, and optoXRs can be delivered using a viral vector with a cell specific synthetic promoter. For example, viral vectors with a TH synthetic promoter have been designed to trace dopamine neuron pathways (Oh et al., [@B100]). This proof-of-principle shows that this approach could be used in different species including, over the long-term, humans.

![**Recovery of motor function following spinal cord injury may be facilitated using combinatorial therapies to promote plasticity within motor networks**. This could be accomplished by targeting monoaminergic systems through the activation of descending brain nuclei using optogenetic or pharmacogenetic approaches, implantation of fetal or embryonic cells from the dopaminergic ventral tegmental area, noradrenergic locus coeruleus or serotonergic raphe nucleus caudal to the site of injury, intrathecal injection of catecholamines and systemic injection of L-DOPA. While these approaches may not be optimal in isolation, they may serve as an effective complementary treatment with rehabilitation and other therapies to reduce secondary injury and promote regeneration of damaged descending tracts to promote the recovery of motor function.](fncir-08-00055-g0005){#F5}

Conclusions {#s10}
===========

This review has focused on the role of dopamine in modulating locomotor centers in the spinal cord. Our knowledge of dopamine's contribution to monoaminergic locomotor drive in mammals is in its infancy. However, parallels to other vertebrate systems, such as the lamprey, clearly exist.

Tools to specifically target dopaminergic and other monoaminergic descending populations now exist. Data from behaving animals suggests that while monoamines generally act to increase tone, they can act to promote specific patterns on their own. While the temptation is to examine each monoaminergic system in isolation, it will be necessary to examine combinatorial actions to start to understand the state-dependent role of monoamines in the freely moving animal.
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